trial · primary record
ETX101
Dravet Syndrome
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 113 |
| Primary completion | 2034-06 |
| Primary endpoint | Percent change in monthly countable seizure frequency (MCSF) between the Pre-Dosing Seizure Period and the Post-Dosing Assessment Period. |
| Registry ID | NCT05419492 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:48.221Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05419492
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.